arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

COGNITION THERAPEUTICS INC

CGTX

$0.95 ▼ -0.04 (-3.66%) at close

27 Visible periods

20 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

COGNITION THERAPEUTICS INC faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $86.1M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -18.5% ↗

FCF / Share $-0.03 ↗

Trailing P/E —

Price / Book 2.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-4.57M

↑ +46.1% —

FCF / Share Free cash flow per share

$-0.03

↑ +45.8% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	63.6% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	64.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	88.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	76.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	38.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	48.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	37.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-13.6% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-12.5% Weak → Weak Stable Year-over-year change in earnings per share Optimal: > 10%	-28.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-35.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	24.1% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	36.0% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	-23.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	96.4% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	94.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	89.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	-52.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	46.1% Excellent ↑ Excellent Improving Year-over-year change in net income	46.1% Excellent ↑ Excellent Improving Year-over-year change in net income	57.4% Excellent ↑ Excellent Improving Year-over-year change in net income	7.3% Fair ↑ Fair Improving Year-over-year change in net income	7.3% Fair ↑ Fair Improving Year-over-year change in net income	7.3% Fair ↑ Fair Improving Year-over-year change in net income	3.7% Caution ↑ Caution Improving Year-over-year change in net income	-48.3% Weak ↑ Weak Improving Year-over-year change in net income	-48.3% Weak ↑ Weak Improving Year-over-year change in net income	-48.3% Weak ↑ Weak Improving Year-over-year change in net income	-57.1% Weak ↑ Weak Improving Year-over-year change in net income	-60.8% Weak ↓ Weak Declining Year-over-year change in net income	-60.8% Weak ↓ Weak Declining Year-over-year change in net income	-60.8% Weak Weak Year-over-year change in net income	29.4% Excellent Excellent Year-over-year change in net income	N/M	N/M	N/M	-292.9% Weak Weak Year-over-year change in net income	N/M	—	—	—	—	—	—	—
FCF Growth YoY (%)	—	61.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	25.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-127.5% Weak Weak Year-over-year change in free cash flow	—	—	—	32.2% Excellent Excellent Year-over-year change in free cash flow	—	—	—	90.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	2.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-3.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—
FCF / Net Income (x)	0.67x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.21x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.16x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.44x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.97x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-0.01x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	—	-4.08x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-3.46x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.26x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-18.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-23.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-31.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-157.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-88.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-45.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-78.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-50.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-38.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-49.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-40.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-25.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.8% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	5.6% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	8.2% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	4.8% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	5.3% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-19.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-71.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-58.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-35.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-52.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-42.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-36.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-43.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-38.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-39.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-57.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-13.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-192%)	-15.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-202%)	-9.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-23.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-255%)	-120.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-904%)	-69.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-561%)	-41.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-379%)	-63.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-521%)	-39.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-365%)	-31.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-311%)	-33.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-322%)	-21.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-242%)	-17.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-220%)	-17.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-215%)	-12.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-186%)	-9.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-8.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-158%)	-7.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-152%)	-14.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-195%)	-0.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-102%)	-0.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-102%)	-0.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-102%)	2.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-82%)	3.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-75%)	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	-1410.20x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-7372.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1969.50x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-897.30x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-930.00x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6312.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1744.71x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1045.89x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-16.76x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-10.40x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.80x Weak Weak Operating income divided by interest expense Optimal: > 5x	-8.78x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-34.01M	$-31.13M	$-36.81M	$-39.33M	$-10.74M	$-16.43M	$-25.01M	$-22.01M	$-28.53M	$-34.67M	$-29.92M	$-32.97M	$-37.19M	$-38.81M	$-41.56M	$-46.61M	$-45.77M	$-51.51M	$-54.72M	$-8.31M	—	—	$-5.19M	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Basic EPS, GAAP (USD)	$-0.04	$-0.05	$-0.02	$-0.06	$-0.11	$-0.14	$-0.17	$-0.25	$-0.18	$-0.27	$-0.27	$-0.22	$-0.16	$-0.21	$-0.20	$-0.29	$-0.25	$-0.17	$11.74	$-8.12	$-4.77	$-1.64	$-5.42	$-5.31	—	—	—
Free Cash Flow per Share (USD)	$-0.03	$-0.06	—	$-0.07	—	$-0.16	—	—	—	$-0.21	—	—	—	$-0.09	—	—	—	$-0.14	—	—	$-1.53	$-1.40	—	—	—	—	—
Book Value per Share (USD)	$0.35	$0.33	$0.39	$0.41	$0.11	$0.20	$0.31	$0.35	$0.57	$0.72	$0.76	$0.95	$1.14	$1.22	$1.39	$1.64	$1.94	$2.16	$2.31	$-140.80	$-141.01	$-123.33	$-126.55	$-123.74	—	—	—
Tangible Book Value per Share (USD)	$0.35	$0.33	$0.39	$0.41	$0.11	$0.20	$0.31	$0.35	$0.57	$0.72	$0.76	$0.95	$1.14	$1.22	$1.39	$1.64	$1.94	$2.16	$2.31	$-140.80	$-141.01	$-123.33	$-126.55	$-123.74	—	—	—
Basic Weighted Avg Shares (shares)	90.62M	89.19M	—	77.95M	63.69M	61.83M	—	40.42M	40.06M	33.74M	—	30.37M	29.61M	29.09M	—	23.02M	22.60M	22.43M	—	611,680	593,431	550,175	—	537,315	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$32.85M	$29.76M	$34.07M	$36.23M	$6.68M	$11.92M	$18.41M	$14.12M	$22.63M	$28.46M	$24.05M	$27.81M	$33.64M	$35.34M	$39.85M	$38.82M	$43.92M	$48.80M	$51.13M	$5.61M	—	—	$3.66M	—	—	—	—
Total Equity (USD)	$33.02M	$29.91M	$34.27M	$36.53M	$7.03M	$12.27M	$18.75M	$14.48M	$23.01M	$28.86M	$24.47M	$28.93M	$34.39M	$35.78M	$40.25M	$39.32M	$43.90M	$48.74M	$51.27M	$-86.72M	$-83.68M	$-67.85M	$-68.18M	$-66.49M	$-64.51M	$-61.97M	$-58.42M

📋 What is driving earnings? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Depreciation Expense (USD)	—	—	$14.00K	$15.00K	—	—	$27.00K	—	—	$27.00K	$27.00K	—	—	$21.00K	$23.00K	—	—	$18.00K	$23.00K	—	$24.00K	$23.00K	$24.00K	—	—	—	—
Net Income, GAAP (USD)	$-4.57M	$-4.57M	$-3.34M	$-8.48M	$-8.48M	$-8.48M	$-7.84M	$-9.15M	$-9.15M	$-9.15M	$-8.14M	$-6.17M	$-6.17M	$-6.17M	$-5.18M	$-3.84M	$-3.84M	$-3.84M	$-7.34M	$223.00K	$223.00K	$223.00K	$-1.87M	$-2.51M	—	—	—
Operating Cash Flow (USD)	$-3.05M	$-5.54M	$-3.44M	$-5.65M	—	$-9.88M	$-8.38M	—	—	$-7.24M	$-5.46M	—	—	$-2.71M	$-10.18M	—	—	$-2.99M	$101.00K	—	$-910.00K	$-772.00K	$-480.00K	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 27 quarters

COGNITION THERAPEUTICS INC

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CGTX with peers